Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trisha M Wise-Draper

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Journal for Immunotherapy of Cancer|October 16, 2020
PD1 blockade enhances K<sup>+</sup> channel activity, Ca<sup>2+</sup> signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancerHannah S Newton, Vaibhavkumar S Gawali, Ameet A Chimote, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Potassium channels mediate the inhibitory effect of exosomes on anti-tumor immunity in head and neck cancerAmeet A Chimote, Abdulaziz O Alshwimi, Simran Venkatraman, et al.
International Journal of Molecular Sciences|March 28, 2024
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome ResistanceAniruddha S Karve, Janki M Desai, Sidharth N Gadgil, et al.
Cancer Research Communications|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaOlga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz, et al.
Cancers|March 13, 2024
Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell CarcinomaAmeet A Chimote, Maria A Lehn, Jay Bhati, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Optimization of head and neck cancer peripheral blood mononuclear cell processing for robust downstream functional immune analysisMargaret Nelson, Katelyn Jansen, Farah Sagin, et al.
Journal for Immunotherapy of Cancer|November 3, 2022
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
The American Journal of Pathology|November 28, 2008
DEK proto-oncogene expression interferes with the normal epithelial differentiation programTrisha M Wise-Draper, Richard J Morreale, Teresa A Morris, et al.
Cancer|October 19, 2019
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancerShuchi Gulati, Janki Desai, Sarah M Palackdharry, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Journal for Immunotherapy of Cancer|October 16, 2020
PD1 blockade enhances K<sup>+</sup> channel activity, Ca<sup>2+</sup> signaling, and migratory ability in cytotoxic T lymphocytes of patients with head and neck cancerHannah S Newton, Vaibhavkumar S Gawali, Ameet A Chimote, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Potassium channels mediate the inhibitory effect of exosomes on anti-tumor immunity in head and neck cancerAmeet A Chimote, Abdulaziz O Alshwimi, Simran Venkatraman, et al.
International Journal of Molecular Sciences|March 28, 2024
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome ResistanceAniruddha S Karve, Janki M Desai, Sidharth N Gadgil, et al.
Cancer Research Communications|May 16, 2025
Phase II Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Patients with Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaOlga Zamulko, Vidhya Karivedu, Muhammad Kashif Riaz, et al.
Cancers|March 13, 2024
Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell CarcinomaAmeet A Chimote, Maria A Lehn, Jay Bhati, et al.
Medrxiv : the Preprint Server for Health Sciences|May 7, 2026
Optimization of head and neck cancer peripheral blood mononuclear cell processing for robust downstream functional immune analysisMargaret Nelson, Katelyn Jansen, Farah Sagin, et al.
Journal for Immunotherapy of Cancer|November 3, 2022
Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2026
Molecular Profiling and Real-World Outcomes of BRAF V600E-Mutated Papillary Thyroid CancerMartina Chirra, Andrew Elliott, Hira Shaikh, et al.
The American Journal of Pathology|November 28, 2008
DEK proto-oncogene expression interferes with the normal epithelial differentiation programTrisha M Wise-Draper, Richard J Morreale, Teresa A Morris, et al.
Cancer|October 19, 2019
Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancerShuchi Gulati, Janki Desai, Sarah M Palackdharry, et al.
Pageof 8